Key Takeaways
- Dental practice valuation relies on three primary methods: income, market, and asset approaches. Each method can produce different results based on buyer type and practice profile.
- The income approach, anchored to normalized EBITDA, is the dominant method for institutional and larger private buyers. The market approach, based on a percentage of collections, is more common in doctor-to-doctor transactions.
- Owner dependence, hygiene production, payer mix, lease terms, and geographic market can be some of the main value drivers that move multiples higher or lower.
- Online valuation calculators rarely produce defensible numbers. A CPA-led, diligence-grade EBITDA analysis helps withstand buyer scrutiny and reduces the risk of re-trading at closing.
- McLerran & Associates delivers side-by-side valuations across both private-buyer and institutional markets and runs a competitive bid process to help maximize outcomes. Schedule a free, confidential discovery call to learn what your practice may be worth in today’s market.
Three-Method Comparison: Income, Market, and Asset Approaches
This comparison table outlines how each method works, when it tends to apply, and the general ranges associated with each buyer type. These figures come from current market sources and should be viewed as directional ranges, not guarantees for any specific practice.
| Method | How Value Is Calculated | Primary Buyer Type | General Range |
|---|---|---|---|
| Income Approach | Normalized EBITDA (or SDE) multiplied by a market multiple, or discounted future cash flows | Institutional or larger private buyers | See detailed EBITDA multiple ranges by buyer type in the table below |
| Market Approach | Percentage of trailing 12-month collections, benchmarked against comparable sales | Individual dentists (doctor-to-doctor) | 65%–85% of annual gross collections for general dentistry |
| Asset Approach | Fair market value of tangible assets plus estimated goodwill, less liabilities | Distressed sales, liquidations, de novo acquisitions | Floor value only; rarely drives headline price for a profitable practice |
The method that governs your transaction usually depends on who is sitting across the table. A sell-side advisor who works both doctor-to-doctor and institutional paths can show you both numbers before you commit to either direction.
Schedule a free, confidential discovery call with McLerran & Associates to discuss which method and buyer type may support the strongest outcome for your practice.
Understand Your Options: The Three Valuation Methods in Depth
The Income Approach
The income approach values a dental practice as an ongoing income stream. It starts with reported earnings, then normalizes them to reflect what the practice might earn under market-based ownership. A multiple that reflects risk and income quality is then applied. This method is usually dominant for practices that attract institutional buyers and for larger private-buyer transactions.
The central concept is normalized EBITDA, which stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Normalized EBITDA is adjusted to remove owner-specific distortions. In plain terms, it answers this question: what would this practice earn if a market-rate dentist were running it with no personal expenses flowing through the books? The normalization process removes personal or discretionary expenses, one-time costs, related-party rent, and staffing anomalies, and replaces the owner’s actual compensation with a defensible market-rate salary for the clinical and managerial roles required after closing.
Common add-backs in a dental EBITDA normalization can include:
- Excess owner compensation above a market-rate replacement dentist salary
- Personal vehicle leases, family travel, or other discretionary expenses run through the practice
- One-time legal, consulting, or equipment costs that are unlikely to recur
- Below-market rent paid to a related-party landlord, adjusted up to market rate
Valuation disputes most often arise from aggressive EBITDA add-backs that do not survive buyer diligence. CPA-led normalization, completed to a diligence-grade standard before the practice goes to market, can reduce that risk. A weak analysis often gets re-traded at the closing table.
EBITDA vs. SDE: What Is the Difference?
SDE, or Seller’s Discretionary Earnings, is a related measure used more often for smaller, owner-operated practices. EBITDA replaces the owner’s compensation with a market-rate salary. SDE adds the owner’s entire compensation package back to net income, reflecting the total economic benefit to a single working owner. SDE is commonly used in smaller doctor-to-doctor transactions, while adjusted EBITDA is the standard in larger institutional and private-equity deals.
This distinction can matter a great deal in real transactions. A doctor-to-doctor buyer using SDE-based pricing and an institutional buyer using EBITDA-based pricing can arrive at very different valuations for the same practice. A sell-side advisor who works in both markets can show you those numbers side by side.
The Market Approach
The market approach benchmarks a practice’s value against comparable sales, most often expressed as a percentage of trailing 12-month collections. General dental practices in private (non-DSO) transactions can trade at 65% to 85% of annual gross collections under this approach. That range would produce a value of $650,000 to $850,000 for a practice collecting $1 million annually.
This method has a structural limitation. Two practices with identical $1 million collections can produce valuations that differ by hundreds of thousands of dollars depending on overhead, because the collections multiple ignores profitability. A practice with 62% overhead and one with 75% overhead collect the same amount, yet they do not have the same value.
The collections benchmark can be a useful starting point for smaller practices and a cross-check for larger ones. It usually should not be the final word on value for a premier practice.
The Asset Approach: When Tangible Value Sets the Floor
The asset approach sums the fair market value of tangible assets such as equipment, leasehold improvements, and supplies, then adds estimated goodwill, which reflects patient relationships, systems, and clinical reputation. For many dental practices, goodwill often comprises 60–85% of total value. As a result, the asset approach typically serves as a floor value rather than the main driver of headline value for a profitable practice.
This method is most relevant for distressed practices, liquidations, early-stage de novo clinics, or as a floor-value cross-check when income and market indications diverge. For a stable, mature general dental practice, the asset approach usually serves as a secondary floor, while the income approach is often primary and the market approach a strong cross-check. The asset approach also matters for tax-allocation planning, because goodwill is typically taxed at long-term capital gains rates, while equipment and non-compete payments are taxed at ordinary income rates.
Create Competition: Why the Same Practice Gets Different Values from Different Buyers
The same dental practice can receive very different offers depending on who is making the offer and which method they use to price it. Buyer type and valuation method often move hand in hand.
| Buyer Type | Valuation Method | Typical General Range | Deal Structure |
|---|---|---|---|
| Individual dentist (doctor-to-doctor) | SDE multiple or % of collections | 60%–80% of trailing 12-month collections | Primarily cash at close via SBA or conventional financing, with a short seller work-back |
| Institutional buyer (add-on) | Normalized EBITDA multiple | 5x–9x adjusted EBITDA for single-location and associate-led groups | Cash at close, rollover equity (often 15–30%), and earnout tied to retained EBITDA |
| Institutional buyer (platform or multi-location group) | Normalized EBITDA multiple | 9x–12x+ EBITDA for multi-location regional groups and platform-grade practices | Larger equity component, multi-year employment agreement, and earnout provisions |
A practice owner who speaks with only one buyer or one buyer type may never see this spread. Doctors frequently have inflated expectations based on deals completed a few years ago, and when current offers come in lower with less cash at closing, they often question whether the deal is worthwhile. In many cases, they also did not run a competitive process to surface the real market.
McLerran & Associates runs a structured, auction-like bid process that typically lasts 45 to 60 days and often generates around 10 offers from a vetted pool of well-qualified buyers. That competition helps control the narrative around your EBITDA and can push both price and terms in your favor. The firm does not simply list practices; it focuses on selling practices.
Schedule a free, confidential discovery call with McLerran & Associates to explore what your practice could be worth in both the private-buyer and institutional markets.
Find the Right Fit: Value Drivers That Move Multiples Up or Down
The multiple applied to your normalized EBITDA can move up or down based on practice-specific factors. Identifying these drivers before going to market and addressing the ones you can influence can be one of the highest-impact steps a seller takes.
Factors that can support a higher multiple include:
- Low owner dependence: Reducing owner dependency can be one of the single biggest value drivers. Practices where the owner produces less than 60–70% of revenue, with associate support and strong hygiene programs, tend to sell faster and at higher multiples.
- Strong hygiene production: Hygiene revenue above 30% of collections and associate-led production are among the highest-impact value drivers that can support premium multiples in 2026 dental transactions.
- Favorable payer mix: Practices with 60% or more private pay can command higher multiples, while heavy Medicaid exposure often reduces them.
- Lease terms with sufficient runway: Lease terms with under 5 years remaining are identified as a multiple-suppressor that can move a dental practice down a valuation band.
- Geographic market: Practices in high-growth metropolitan markets can command a premium over rural or slow-growth markets in DSO transactions.
- Clean financials and documented systems: Reporting quality, staff stability, and compliance maturity can reduce buyer-perceived risk and support stronger multiples.
Factors that can suppress a multiple include:
- Heavy concentration of production in the owner-doctor
- Significant Medicaid or government-payer exposure
- Deferred equipment maintenance or aging technology
- Declining collections trends or patient attrition
- Short or unfavorable lease terms
Free or back-of-the-napkin valuations rarely account for these drivers with much precision. A number set by a buyer or generated by an online calculator often becomes the anchor that quietly determines what you walk away with. When that number has not been stress-tested, it can get re-traded in diligence.
Maximize Your Outcome: How McLerran & Associates Applies the Methods
McLerran & Associates has guided practice owners through roughly 2,000 successful sales and more than $2 billion in closed transaction volume, evaluating over 10,000 practices across its 35-year history. Every engagement begins with a CPA-led, diligence-grade EBITDA analysis that is designed to hold up when a buyer’s quality-of-earnings team reviews the numbers.
For doctor-to-doctor transactions, the firm applies the market approach and SDE-based income method to establish a defensible asking price, then takes the practice to the largest premier private-buyer pool in the country. When the practice profile suggests that institutional buyers may pay a premium, the firm shifts to controlling the narrative around normalized EBITDA, unpacking every add-back, defending the analysis through diligence, and reminding buyers that a vetted pool of competing bidders is waiting if they attempt to trade the deal down.
Many practices fall into a gray zone. Practices in the $1.5 million to $3 million revenue range can attract competitive offers from either market. For these owners, McLerran produces a true side-by-side valuation, quantifying the practice’s worth in both markets so the owner chooses a path with fuller information rather than a guess.
EBITDA multiples for larger dental practices have risen in recent years as buyer competition increased. North American institutional deal activity has become more selective since its 2021 peak, yet demand for premier, Class A practices remains active. Institutional buyers represent a substantial share of transactions and can sometimes pay a meaningful premium over individual buyers for well-located, profitable practices.
The McLerran transaction rate of approximately 85–90%, compared with an industry norm closer to 35–40%, reflects what can happen when diligence-grade valuation work is paired with a structured competitive process and sell-side-only advocacy from first conversation to closed deal.
What Is the Best Way to Value a Dental Practice?
A practical way to value a dental practice is to apply the method most relevant to the likely buyer and to complete that work to a diligence-grade standard before the practice goes to market.
For many premier practices generating $1 million or more in annual collections, the income approach anchored to normalized EBITDA can be the most defensible and most relevant method, particularly when DSO or private equity buyers are involved. The market approach, based on a collections percentage, often serves as a useful cross-check for smaller practices and doctor-to-doctor transactions. The asset approach usually provides a floor and informs tax-allocation planning but rarely drives headline value for a profitable going concern.
McLerran & Associates’ process begins with a CPA and deal advisor remotely accessing the practice’s management software, pulling the necessary reports, and cross-referencing the data against the financials. They unpack discretionary, personal, and non-recurring expenses to arrive at a view of true profitability. The result is a number that most accountants would recognize as high quality and that is less likely to be re-traded when buyers scrutinize it.
For owners weighing both paths, the firm delivers a side-by-side valuation that quantifies worth in both the private-buyer and DSO markets. That structure helps the owner make a decision with fuller information rather than a guess.
How Many Times EBITDA Is a Dental Practice Worth?
The multiple a dental practice can command often depends on the size of the practice, the buyer type, and the quality of the normalized EBITDA. There is no single fixed multiple, and any advisor who quotes one without knowing your specific numbers may not be serving your interests.
As a directional framework based on current 2026 market data:
- Smaller solo general dentistry practices can trade at 4x–6x EBITDA, reflecting greater buyer sensitivity to owner dependency and operational risk.
- Mature multi-OD optometry groups with $1M to $3M in adjusted EBITDA trade at approximately 6x to 8.5x adjusted EBITDA as PE-backed platforms execute tuck-in strategy.
- Emerging multi-location platforms can reach 9x–11x EBITDA, and platform-grade practices with $5 million or more in EBITDA can reach 10x–12x or higher.
- Specialty practices can command different ranges from general dentistry, with the specific premium varying by specialty, scale, and buyer demand in a given market.
Value drivers such as owner dependence, hygiene strength, payer mix, lease terms, provider bench depth, and the quality of the competitive process often move a practice toward the top or bottom of its range. Practices where the owner produces more than 90% of total doctor production can trade at a meaningfully lower multiple due to patient attrition risk after transition.
Dental Practice Valuation Calculator
Online dental practice valuation calculators are widely available and often misunderstood. A calculator that takes your collections and applies a fixed percentage, or takes a rough EBITDA figure and multiplies it by a generic number, cannot produce a defensible valuation. It can provide a starting point at best and a misleading anchor at worst.
A true valuation requires normalized EBITDA built from the ground up. Actual financials are reviewed, add-backs are unpacked and defended, owner compensation is replaced with a market-rate equivalent, and the resulting number is stress-tested against what a disciplined buyer might accept in diligence. A dental practice is worth what a disciplined buyer is willing to pay after converting reported financials into buyer-accepted normalized EBITDA, testing whether revenue and provider economics are transferable, and adjusting for risks that could reduce post-close cash flow.
No calculator performs that level of work. A CPA-led advisor does.
The risk of relying on a free or automated valuation is not only an imprecise number. The number can also become the anchor for your negotiation. McLerran & Associates has seen cases where a free valuation significantly undervalued a practice, while a diligence-grade analysis and competitive process produced a materially higher outcome. The quality of the valuation work can influence every stage of the transaction.
Schedule a free, confidential discovery call with McLerran & Associates and explore what your practice may be worth with CPA-led analysis to support the number.
Conclusion: How McLerran & Associates Helps You Navigate Valuation and Sale
Dental practice valuation methods are not interchangeable. The income, market, and asset approaches can produce different numbers for different buyers. A sell-side advisor who runs both the doctor-to-doctor and DSO paths with CPA-led EBITDA analysis can help you see a fuller picture before you choose a direction.
The McLerran & Associates approach integrates these valuation methods into a comprehensive sell-side process. First, the firm delivers a diligence-grade valuation that quantifies your worth in both the private-buyer and institutional markets before you commit to either path. Then it creates competition through a structured, auction-like process among a vetted pool of well-qualified buyers that surfaces real market value and generates competitive tension.
Throughout the process, the firm helps you identify a buyer whose strategy, structure, and support model protect your legacy, patients, and staff alongside the financial outcome. Finally, McLerran defends the EBITDA narrative through diligence, negotiates the terms of the letter of intent, and works to close at the agreed value.
You sell once. Buyers negotiate every week. One of the biggest determinants of what you walk away with is whether you have a sell-side advocate who controls the narrative around your value from the first conversation to the closing table.
Schedule a free, confidential discovery call with McLerran & Associates by calling (512) 900-7989, emailing info@dentaltransitions.com, or visiting dentaltransitions.com/contact-us.
Frequently Asked Questions
What is the difference between EBITDA and SDE in a dental practice valuation?
EBITDA, or Earnings Before Interest, Taxes, Depreciation, and Amortization, is calculated by replacing the owner-dentist’s actual compensation with a market-rate salary for the clinical and managerial roles required after the sale. The result reflects what the practice might earn under any qualified owner, which is why it is the standard metric for DSO and private equity buyers who are acquiring the practice as an investment rather than a job. SDE, or Seller’s Discretionary Earnings, adds the owner’s entire compensation package back to net income, capturing the total economic benefit available to a single working owner. SDE is more commonly used in smaller doctor-to-doctor transactions where the buyer intends to work in the practice full-time. The practical difference can be significant. A practice with a high owner salary will show a lower EBITDA than SDE, which means the two methods can produce materially different valuations for the same practice. Knowing which metric a given buyer will use, and having a CPA-led analysis that supports your number under either framework, can be essential before entering any negotiation.
Why do DSO buyers pay higher multiples than individual dentists?
DSO and private equity buyers often value a dental practice differently from an individual dentist because they are acquiring it as a platform investment, not a personal income stream. An individual dentist buying a practice is constrained by what SBA or conventional financing will support, which is typically tied to the practice’s ability to service debt from its cash flow. That ceiling limits how aggressively they can bid. A DSO or private equity platform, by contrast, deploys institutional capital and values the practice based on its contribution to a larger portfolio, including shared infrastructure, the ability to add providers, and the potential multiple expansion that comes from building a larger group. This dynamic helps explain why the same practice can receive a meaningfully higher headline offer from an institutional buyer than from an individual dentist. The trade-off often appears in deal structure. DSO offers typically include a mix of cash at close, rollover equity held in the DSO, and an earnout tied to future performance, which means the headline number and the actual cash in your pocket at closing can be very different figures. A sell-side advisor who models the full economic outcome across all components of the deal, not just the headline, can be helpful for making an informed comparison.
How does owner dependence affect a dental practice’s valuation?
Owner dependence, or the degree to which the practice’s revenue is concentrated in the owner-dentist personally, can be one of the most consequential value drivers in a dental practice sale. When the owner produces the majority of the practice’s revenue, buyers face a meaningful risk. If patients follow the departing doctor rather than staying with the practice, post-close cash flow could decline significantly. Buyers price that risk into the multiple they are willing to pay and often apply a discount to practices where the owner accounts for a large share of production. Practices where associate dentists and a strong hygiene program generate a substantial portion of revenue are viewed as more transferable. The income stream is less dependent on any single individual, which reduces buyer risk and can support a higher multiple. Reducing owner dependence before going to market by building out an associate team, strengthening the hygiene program, and documenting systems can be one of the most effective ways to improve valuation outcomes. A sell-side advisor can help you identify which improvements are worth making before the practice goes to market and which are unlikely to move the needle materially.
What is rollover equity in a DSO transaction, and how should I evaluate it?
Rollover equity, sometimes called retained equity, is the portion of a DSO deal paid not in cash but in ownership stakes in the acquiring DSO or its parent company. In a typical DSO transaction, a meaningful share of the total deal value may be structured as equity rather than cash at close, with the expectation that the seller may realize additional value when the DSO itself is eventually sold or recapitalized. Equity can be held at two levels. Joint-venture level equity typically provides distributions and a more predictable return but a lower ceiling. Holding-company level equity offers no distributions but the potential for a larger payout if the DSO performs well and achieves a successful exit. Evaluating rollover equity requires underwriting the DSO itself as an investment. That process can include assessing whether the overall company is profitable, whether revenue is still growing at the practices it already owns, whether the management team is experienced, and whether the private equity firm backing it has a track record of successful exits. McLerran & Associates vets buyers like investments, steering clients toward well-backed, well-run partners and away from undercapitalized or poorly integrated platforms that could put retained equity at risk.
Is now a good time to sell a dental practice?
Demand for premier, Class A dental practices remains active in 2026, and valuations for well-run practices with strong fundamentals continue to sit near historically high levels. At the same time, the market has become more selective. Buyers place greater emphasis on profitability over revenue, owner dependence is being priced more carefully, and deal structures have evolved, with longer employment agreements and more complex equity components becoming more common in institutional transactions. The right time to sell usually depends on your specific practice, your financial goals, and your personal timeline rather than on a generalized market forecast. A practice that is growing, has low owner dependence, strong hygiene production, and clean financials will often attract competitive offers in a wide range of market environments. A practice with deferred maintenance, declining trends, or heavy owner concentration may benefit from a period of preparation before going to market. McLerran & Associates provides candid assessments of where a practice stands and what, if anything, may be worth addressing before a sale. If you are not ready to transact, the firm can update your valuation at no charge a year later rather than push you into a deal before the time feels right.
